This study was aimed at the characterization of a gene expression signature of the pluripotent hematopoietic CD34(+) stem cell in idiopathic myelofibrosis (IM), which would eventually provide novel pathogenetic insights and/or diagnostic/prognostic information. Aberrantly regulated genes were revealed by transcriptome comparative microarray analysis of normal and IM CD34(+) cells; selected genes were also assayed in granulocytes. One-hundred seventy four differentially expressed genes were identified and in part validated by quantitative polymerase chain reaction. Altered gene expression was corroborated by the detection of abnormally high CD9 or CD164, and low CXCR4, membrane protein expression in IM CD34(+) cells. According to class prediction analysis, a set of eight genes (CD9, GAS2, DLK1, CDH1, WT1, NFE2, HMGA2, and CXCR4) properly recognized IM from normal CD34(+) cells. These genes were aberrantly regulated also in IM granulocytes that could be reliably differentiated from control polycythemia vera and essential thrombocythemia granulocytes in 100% and 81% of cases, respectively. Abnormal expression of HMGA2 and CXCR4 in IM granulocytes was dependent on the presence and the mutational status of JAK2(V617F) mutation. The expression levels of both CD9 and DLK1 were associated with the platelet count, whereas higher WT1 expression levels identified IM patients with more active disease, as revealed by elevated CD34(+) cell count and higher severity score. In conclusion, molecular profiling of IM CD34(+) cells uncovered a limited number of genes with altered expression that, beyond their putative role in disease pathogenesis, are associated with patients' clinical characteristics and may have potential prognostic application.

Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) / Guglielmelli, P; Zini, Roberta; Bogani, C; Salati, Simona; Pancrazzi, A; Bianchi, Elisa; Mannelli, F; Ferrari, Sergio; Le Bousse Kerdilès, Mc; Bosi, A; Barosi, G; Migliaccio, Ar; Manfredini, Rossella; Vannucchi, A. M.. - In: STEM CELLS. - ISSN 1066-5099. - STAMPA. - 25:(2007), pp. 165-173. [10.1634/stemcells.2006-0351]

Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)

ZINI, Roberta;SALATI, Simona;BIANCHI, Elisa;FERRARI, Sergio;MANFREDINI, Rossella;
2007

Abstract

This study was aimed at the characterization of a gene expression signature of the pluripotent hematopoietic CD34(+) stem cell in idiopathic myelofibrosis (IM), which would eventually provide novel pathogenetic insights and/or diagnostic/prognostic information. Aberrantly regulated genes were revealed by transcriptome comparative microarray analysis of normal and IM CD34(+) cells; selected genes were also assayed in granulocytes. One-hundred seventy four differentially expressed genes were identified and in part validated by quantitative polymerase chain reaction. Altered gene expression was corroborated by the detection of abnormally high CD9 or CD164, and low CXCR4, membrane protein expression in IM CD34(+) cells. According to class prediction analysis, a set of eight genes (CD9, GAS2, DLK1, CDH1, WT1, NFE2, HMGA2, and CXCR4) properly recognized IM from normal CD34(+) cells. These genes were aberrantly regulated also in IM granulocytes that could be reliably differentiated from control polycythemia vera and essential thrombocythemia granulocytes in 100% and 81% of cases, respectively. Abnormal expression of HMGA2 and CXCR4 in IM granulocytes was dependent on the presence and the mutational status of JAK2(V617F) mutation. The expression levels of both CD9 and DLK1 were associated with the platelet count, whereas higher WT1 expression levels identified IM patients with more active disease, as revealed by elevated CD34(+) cell count and higher severity score. In conclusion, molecular profiling of IM CD34(+) cells uncovered a limited number of genes with altered expression that, beyond their putative role in disease pathogenesis, are associated with patients' clinical characteristics and may have potential prognostic application.
2007
25
165
173
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) / Guglielmelli, P; Zini, Roberta; Bogani, C; Salati, Simona; Pancrazzi, A; Bianchi, Elisa; Mannelli, F; Ferrari, Sergio; Le Bousse Kerdilès, Mc; Bosi, A; Barosi, G; Migliaccio, Ar; Manfredini, Rossella; Vannucchi, A. M.. - In: STEM CELLS. - ISSN 1066-5099. - STAMPA. - 25:(2007), pp. 165-173. [10.1634/stemcells.2006-0351]
Guglielmelli, P; Zini, Roberta; Bogani, C; Salati, Simona; Pancrazzi, A; Bianchi, Elisa; Mannelli, F; Ferrari, Sergio; Le Bousse Kerdilès, Mc; Bosi, A; Barosi, G; Migliaccio, Ar; Manfredini, Rossella; Vannucchi, A. M.
File in questo prodotto:
File Dimensione Formato  
33. stem cells_IMF_2007.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 956.68 kB
Formato Adobe PDF
956.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/718648
Citazioni
  • ???jsp.display-item.citation.pmc??? 55
  • Scopus 108
  • ???jsp.display-item.citation.isi??? 103
social impact